Using AI to Slash Cancer Diagnosis Wait Time

The race to apply advanced AI tools to the war on cancer is starting to take shape, with giants like MIT and Google, as well as specialized health-tech companies like Nucleai optimizing the cancer diagnosis process. With a major shortage of pathologists and a growing pile of biopsies that require attention, which are the only diagnostic procedure that can conclusively identify cancerous tissue, AI can make pathologists’ workflow more efficient and drastically reduce wait-times for diagnoses, potentially saving patients’ lives.

Nucleai’s tool can be leveraged by pathologists to improve workflow, increase efficiency and reduce potential missed diagnoses. Backed by over 20 million slides, Nucleai’s team of sought-after leaders in the fields AI, machine learning, and machine vision are the only players in the space to have unlocked a complete solution supporting several types of biopsies (gastro, breast and prostate) in only 1.5 years.

Media Contact:

Emily Smouha  |  Account Coordinator

IL:+972 54 612 7392
US: +1 914 336 4428
UK: +44 203 468 7174
Source: WWW.HEADLINE.MEDIA